Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$38.9M | -$72.8M | -$126M | -$131M | -$116M | -$93.3M |
| Net income | -$38.4M | -$72.7M | -$124M | -$124M | -$111M | -$90.6M |
| EPS (diluted) | -$39.50 | -$4.10 | -$2.76 | -$1.68 | -$1.31 | -$0.59 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$35.4M | -$60.8M | -$104M | -$102M | -$90.5M | -$68.3M |
| Capital expenditures | $9.76M | $25.1M | $20.6M | $1.24M | $1.02M | $618K |
| Free cash flow | -$45.2M | -$85.9M | -$125M | -$103M | -$91.5M | -$68.9M |
| Share buybacks | $1.00K | $13.0K | — | — | — | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $129M | $38.1M | $95.3M | $45.7M | $4.32M | $101M |
| Total assets | $148M | $314M | $279M | $171M | $120M | $147M |
| Total liabilities | $8.72M | $35.7M | $35.6M | $31.1M | $27.1M | $23.7M |
| Shareholders' equity | -$81.3M | $279M | $243M | $139M | $92.9M | $123M |
| Retained earnings | -$82.8M | -$156M | -$279M | -$403M | -$514M | -$605M |
| Shares (wtd avg diluted) | 1.21M | 17.7M | 44.8M | 73.8M | 84.8M | 153M |
Every figure is extracted from Tenaya Therapeutics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.